Paige Predict
AI-powered digital pathology for biomarker prediction from H&E images.
Executive Summary
Paige Predict is an advanced AI-powered digital pathology solution developed by Tempus AI. It is designed to analyze digitized images of H&E-stained pathology slides to predict the presence of genomic and phenotypic biomarkers. This capability is particularly valuable in scenarios where tissue samples are limited, enabling clinicians and researchers to gain rapid access to crucial insights without the need for additional invasive procedures or extensive sample processing. The solution leverages sophisticated AI models to forecast tissue nucleic acid (TNA) yield, which helps identify samples at risk of Next-Generation Sequencing (NGS) failure. By providing these predictions, Paige Predict helps optimize the use of precious tissue samples, streamline diagnostic workflows, and accelerate research into precision medicine. It transforms raw pathology images into actionable intelligence, advancing biomarker screening at scale.
Use Cases
- Predicting genomic and phenotypic biomarker presence from H&E images.
- Forecasting tissue nucleic acid (TNA) yield to assess sample quality.
- Identifying tissue samples at risk of Next-Generation Sequencing (NGS) failure.
- Guiding treatment decisions and research when tissue samples are limited.
- Advancing biomarker screening at scale in oncology and other fields.
Features
Intelligence
- AI-Powered Biomarker Prediction: Analyzes H&E whole slide images to predict genomic and phenotypic biomarker presence.
- Tissue Nucleic Acid (TNA) Yield Forecasting: Forecasts TNA yield to identify samples at risk of NGS failure, optimizing sample use.
- Digital Pathology Analysis: Transforms digitized H&E slides into actionable insights for precision medicine.
Technical Specifications
- Architecture
- AI system that analyzes digitized images, implying a cloud-based processing architecture.
- Deployment
- SaaS
Integrations
- EHR/EMR Systems
Pricing
- Starting Price
- Contact sales
- Target Customer
- Enterprise
- Contract Type
- Annual
About Tempus AI
Tempus AI is a healthcare technology company that leverages data and artificial intelligence to provide precision medicine services, including diagnostics, for various therapeutic areas such as oncology, cardiology, radiology, and depression. The company has built one of the world's largest libraries of clinical and molecular data, along with an operating system to make this data accessible and useful for personalized patient care and accelerating therapeutic discovery.
Alternatives to Paige Predict
- PandaOmics by Insilico Medicine — AI-powered platform for therapeutic target and biomarker discovery and prioritization.
- PanOmics by Evotec — Comprehensive multi-omics data generation and analysis for advanced drug discovery.
- Pharma.AI by Insilico Medicine — Accelerating drug discovery and development with end-to-end generative AI and automation.
- phenAID by Ardigen — AI-powered image-based virtual screening and phenotypic profiling platform
- PipeBio Antibodies by Benchling — Accelerate AI-powered antibody discovery and development.
- POSH Platform by Insitro — AI-powered platform for gene function reconstruction and accelerated drug discovery.
- PreciousGPT by Insilico Medicine — AI models for digital -omics experiments and drug discovery.
- Recursion OS by Recursion Pharmaceuticals — Decoding biology to radically improve lives through AI-driven drug discovery.